SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001104659-23-054683
Filing Date
2023-05-02
Accepted
2023-05-01 21:29:43
Documents
7
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A tm2313284d1_6ka.htm 6-K/A 15268
2 EXHIBIT 99.1 tm2313284d1_ex99-1.htm EX-99.1 1119064
3 EXHIBIT 99.2 tm2313284d1_ex99-2.htm EX-99.2 657655
4 EXHIBIT 99.3 tm2313284d1_ex99-3.htm EX-99.3 8631
5 EXHIBIT 99.4 tm2313284d1_ex99-4.htm EX-99.4 8584
6 GRAPHIC tm2313284d1_ex99-2img01.jpg GRAPHIC 4140
7 GRAPHIC tm2313284d1_ex99-1img001.jpg GRAPHIC 5565
  Complete submission text file 0001104659-23-054683.txt   1824013
Mailing Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8
Business Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8 604-218-4766
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 333-249081 | Film No.: 23876338
SIC: 2833 Medicinal Chemicals & Botanical Products